[go: up one dir, main page]

CA2467433A1 - Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer - Google Patents

Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer Download PDF

Info

Publication number
CA2467433A1
CA2467433A1 CA002467433A CA2467433A CA2467433A1 CA 2467433 A1 CA2467433 A1 CA 2467433A1 CA 002467433 A CA002467433 A CA 002467433A CA 2467433 A CA2467433 A CA 2467433A CA 2467433 A1 CA2467433 A1 CA 2467433A1
Authority
CA
Canada
Prior art keywords
cancer
protein
sequence
nucleic acid
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002467433A
Other languages
English (en)
Inventor
Daniel Afar
Natasha Aziz
Wendy M. Ginsburg
Kurt C. Gish
Richard Glynne
Peter A. Hevezi
David H. Mack
Richard Murray
Susan R. Watson
Keith E. Wilson
Albert Zlotnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EOS Biotechnology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2002/036810 external-priority patent/WO2003042661A2/fr
Publication of CA2467433A1 publication Critical patent/CA2467433A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Cette invention concerne des gènes dont l'expression est régulée positivement ou négativement dans certains cancers ou pathologies spécifiques, ou bien dont l'expression est régulée dans les états pathologiques. Sont également décrites des méthodes et des compositions connexes convenant pour le diagnostic, le pronostic et le traitement de ces pathologie ainsi que ces méthodes permettant d'identifier les modulateurs de ces dernières.
CA002467433A 2001-11-13 2002-11-13 Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer Abandoned CA2467433A1 (fr)

Applications Claiming Priority (37)

Application Number Priority Date Filing Date Title
US35066601P 2001-11-13 2001-11-13
US60/350,666 2001-11-13
US33246401P 2001-11-21 2001-11-21
US60/332,464 2001-11-21
US33439301P 2001-11-29 2001-11-29
US60/334,393 2001-11-29
US33539401P 2001-12-03 2001-12-03
US60/335,394 2001-12-03
US34037601P 2001-12-14 2001-12-14
US60/340,376 2001-12-14
US34721102P 2002-01-08 2002-01-08
US60/347,211 2002-01-08
US34734902P 2002-01-10 2002-01-10
US60/347,349 2002-01-10
US35525002P 2002-02-08 2002-02-08
US60/355,250 2002-02-08
US35671402P 2002-02-13 2002-02-13
US60/356,714 2002-02-13
US35907702P 2002-02-20 2002-02-20
US60/359,077 2002-02-20
US36880902P 2002-03-29 2002-03-29
US60/368,809 2002-03-29
US37011002P 2002-04-04 2002-04-04
US60/370,110 2002-04-04
US37224602P 2002-04-12 2002-04-12
US60/372,246 2002-04-12
US38661402P 2002-06-05 2002-06-05
US60/386,614 2002-06-05
US39683902P 2002-07-16 2002-07-16
US60/396,839 2002-07-16
US39784502P 2002-07-22 2002-07-22
US39777502P 2002-07-22 2002-07-22
US60/397,845 2002-07-22
US60/397,775 2002-07-22
US40945002P 2002-09-09 2002-09-09
US60/409,450 2002-09-09
PCT/US2002/036810 WO2003042661A2 (fr) 2001-11-13 2002-11-13 Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer

Publications (1)

Publication Number Publication Date
CA2467433A1 true CA2467433A1 (fr) 2003-05-22

Family

ID=32719847

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002467433A Abandoned CA2467433A1 (fr) 2001-11-13 2002-11-13 Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer

Country Status (4)

Country Link
EP (1) EP1497454A2 (fr)
JP (1) JP2005525789A (fr)
AU (1) AU2002357734A1 (fr)
CA (1) CA2467433A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US20040229232A1 (en) * 2002-09-11 2004-11-18 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
PT2325305E (pt) 2005-02-25 2014-04-29 Oncotherapy Science Inc Vacinas peptídicas para cancros do pulmão que expressam polipéptidos ttk, urlc10 ou koc1
WO2008104803A2 (fr) * 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Protéines
WO2009016691A1 (fr) * 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Gène ly6k associé au cancer
NZ587506A (en) * 2008-01-25 2012-09-28 Univ Aarhus Selective exosite inhibition of papp-a activity against igfbp-4
JPWO2011115268A1 (ja) * 2010-03-18 2013-07-04 大日本住友製薬株式会社 腫瘍血管新生阻害剤

Also Published As

Publication number Publication date
JP2005525789A (ja) 2005-09-02
EP1497454A2 (fr) 2005-01-19
AU2002357734A1 (en) 2003-05-26

Similar Documents

Publication Publication Date Title
US7435589B2 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US7736853B2 (en) Methods of diagnosis of androgen-dependent prostate cancer, prostate cancer undergoing androgen withdrawal, and androgen-independent prostate cancer
US20050181375A1 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
CA2451465A1 (fr) Procedes de diagnostic du cancer ovarien, compositions et procedes de criblage de modulateurs du cancer ovarien
CA2440703A1 (fr) Procedes de diagnostic du cancer du sein, compositions et procedes de criblage de modulateurs du cancer du sein
CA2459219A1 (fr) Procedes de diagnostic du cancer, compositions et procedes de criblage de modulateurs du cancer
CA2453098A1 (fr) Procede de diagnostic du cancer de la vessie, compositions et procedes de criblage de modulateurs du cancer de la vessie
WO2004048938A2 (fr) Procedes de detection du sarcome des tissus mous, compositions et procedes de criblage des modulateurs du sarcome des tissus mous
US20030124579A1 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
CA2425569A1 (fr) Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate
US20070054268A1 (en) Methods of diagnosis and prognosis of ovarian cancer
US20030235820A1 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
CA2444691A1 (fr) Procedes de diagnostic du cancer du poumon, compositions et procedes de criblage de modulateurs du cancer du poumon
US20030232350A1 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20040029114A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US20100297152A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20030228570A1 (en) Methods of diagnosis of Hepatitis C infection, compositions and methods of screening for modulators of Hepatitis C infection
CA2438030A1 (fr) Methode de diagnostic de l'angiogenese, preparations et methodes d'identification par criblage de modulateurs de l'angiogenese
US20070178458A1 (en) Methods of diagnosis and prognosis of ovarian cancer II
US20060154250A1 (en) Novel compositions and methods in cancer
WO2004073657A2 (fr) Methode de diagnostic du cancer, composition et methodes de criblage destinees a identifier des modulateurs du cancer
CA2381699A1 (fr) Nouvelles techniques de diagnostic de l'angiogenese, compositions et techniques de criblage pour modulateurs d'angiogenese
US20070042360A1 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
CA2467433A1 (fr) Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer
US20020068036A1 (en) Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators

Legal Events

Date Code Title Description
FZDE Discontinued